Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs FIVN✓SelectedUSD · FIVNGSK vs FIVN performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs FIVN

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+80.1%
FIVN return
+238.7%
Excess return
-158.7%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioFIVNExcessAlpha
1D-0.1%-1.4%+1.3%0.0%
7D-1.3%-6.7%+5.4%-1.0%
30D+2.7%-16.4%+19.2%+3.4%
3M+2.7%-18.4%+21.1%+3.4%
6M+3.3%+24.4%-21.1%+1.7%
YTD+6.5%+34.3%-27.9%+4.0%
1Y+10.7%+32.9%-22.2%+8.0%
3Y+64.4%-62.9%+127.3%+69.9%
5Y+46.7%-83.8%+130.5%+56.7%
10Y+109.4%+79.7%+29.7%+87.5%
All+80.1%+238.7%-158.7%+57.8%

Cumulative growth

Daily Returns

Daily percentage return beside FIVN.

Daily Out/Under-Performance

Portfolio return minus FIVN return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × FIVN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded FIVN wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling